Vertex's Trikafta pricing central to cystic fibrosis treatment disparities, study says
The cost of a popular Vertex Pharmaceuticals therapy could be contributing to cystic fibrosis (CF) treatment disparities around the...
Everything You Need to Know About Xerophthalmia
Xerophthalmia is an eye condition that results from vitamin A deficiency. Symptoms include dry eyes, night vision difficulty, and lesions...
AbbVie, Galapagos’ Kalydeco challenger clears phase 2
Galapagos has posted phase 2 data on the cystic fibrosis drug it is developing with AbbVie. The data suggest the potentiator can play a...
Kaftrio Boosts Exercise Capacity in Teens With CF, Case Analysis Shows
A six-week treatment with Kaftrio led to marked improvement in exercise capacity in adolescents with cystic fibrosis (CF), according to...
Prioritizing treatment burden important for patients with cystic fibrosis
Findings published in Chest highlighted the importance of routinely capturing treatment burden among individuals with cystic fibrosis in...
Change of antibiotic is not associated with improved expiratory volume response in patients with fib
Although advances in treatment lead to improvements in care, change does not reflect changes in the patient. Pulmonary exacerbation is...